<p>➀ Researchers at IISc developed a vanadium-based nanozyme to combat abnormal blood clotting by mimicking antioxidant enzymes and reducing reactive oxygen species (ROS) levels;</p><p>➁ The V₂O₅ nanozymes effectively suppressed platelet overactivation in human blood and reduced thrombosis in a mouse model of pulmonary thromboembolism (PTE) without harmful side effects;</p><p>➂ Unlike traditional antiplatelet drugs, the nanozymes modulate redox signaling without interfering with normal clotting, potentially reducing bleeding risks associated with current therapies.</p>